发布时间 : 星期六 文章六分钟步行试验指南更新完毕开始阅读cf3795244b35eefdc8d333e2
验广泛应用于心肺疾病治疗干预前后的临床评价。本指南提供了一个进行6MWT的标准方法。制定该指南的委员会希望它能鼓励大家对6MWT进行更深入的研究并使不同的研究之间具有可比性。 附件
下列项目应在6MWT工作表和报告上详细填写 圈数计数器:__ __ __ __ ____ __ __ __ __ __ __ __ __ __ 患者姓名: ____________________ 患者 ID# ___________ 试验编号 # ______ 技术员 ID: _________ 日期: __________ 性别: M F 年龄: ____ 民族: ____ 身高: ___ft ____in, ____ meters 体重: ______lbs, _____kg 血压:_____ / _____ 试验前用药 (剂量和时间): __________________ 试验时是否需要氧气: 否/是, 流量 ______ L/min, 方式 _____ 时间 心率 呼吸困难 疲倦 SpO2 基线 ___:___ _____ ____ ____ ____ % 试验结束 ___:___ _____ ____ (Borg 量表) ____ (Borg 量表) ____% 试验是否提前结束? 否 是, 原因: _______________ 试验结束时的其他症状: 心绞痛 头晕 臀、大腿或小腿痛 圈数: ____ (x60米) + 最后未完成的一圈: _____ 米 = 6分钟步行总 距离: ______ 米 预计值: _____米 占预计值百分比: _____% 技术员注解: 结论(包括与干预前6MWD的比较): 参考文献
1. Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ. Principles of exercise testing and interpretation, 3rd edition. Philadelphia: Lippincott, Williams & Wilkins; 1999.
2. Weisman IM, Zeballos RJ. An integrated approach to the
interpretation of cardiopulmonary exercise testing. Clin Chest Med 1994;15:421–445.[Medline]
3. Fletcher GF, Balady G, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards: a statement for healthcare professionals from the American Heart Association: writing group.
Circulation 1995; 91:580–615.[Free Full Text]
4. Pina IL, Balady GJ, Hanson P, Labovitz AJ, Madonna DW, Myers J. Guidelines for clinical exercise testing laboratories: a statement for healthcare professionals from the Committee on Exercise and Cardiac Rehabilitation, American Heart Association. Circulation 1995;91:912–921.[Medline]
5. Balke B. A simple field test for the assessment of physical fitness.
CARI Report 1963;63:18.
6. Cooper KH. A means of assessing maximal oxygen intake: correlation between field and treadmill testing. JAMA 1968;203:201–204.[CrossRef][Medline]
7. McGavin CR, Gupta SP, McHardy GJR. Twelve-minute walking test for assessing disability in chronic bronchitis. BMJ 1976;1:822–823. 8. Butland RJA, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. BMJ 1982; 284:1607–1608.
9. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001;119:256–270.[Abstract/Free Full Text]
10.Kadikar A, Maurer J, Kesten S. The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant 1997;16: 313–319.[Medline]
11.Holden DA, Rice TW, Stelmach K, Meeker DP. Exercise testing, 6 min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest
1992;102:1774–1779.[Abstract/Free Full Text]
12.Sciurba FC, Rogers RM, Keenan RJ, Slivka WA, Gorcsan J 3rd, Ferson PF, Holbert JM, Brown ML, Landreneau RJ. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med
1996;334:1095–1099.[Abstract/Free Full Text]
13.Criner GJ, Cordova FC, Furukawa S, Kuzma AM, Travaline JM, Leyenson V, O'Brien GM. Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe COPD. Am J Respir Crit Care Med
1999;160:2018–2027.[Abstract/Free Full Text]
14.Sinclair DJM, Ingram CG. Controlled trial of supervised exercise training in chronic bronchitis. BMJ 1980;280:519–521.
15.Roomi J, Johnson MM, Waters K, Yohannes A, Helm A, Connolly MJ. Respiratory rehabilitation, exercise capacity and quality of life in chronic airways disease in old age. Age Ageing 1996;25:12–16.[Abstract/Free Full Text]
16.Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with COPD. Lancet 1998;351:773–780.[CrossRef][Medline]
17.Leggett RJ, Flenley DC. Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pulmonale. BMJ 1977;2:84–86. 18.Spence DPS, Hay JG, Carter J, Pearson MG, Calverley PMA. Oxygen desaturation and breathlessness during corridor walking in COPD: effect of oxitropium bromide. Thorax 1993;48:1145–1150.[Abstract]
19.DeBock V, Mets T, Romagnoli M, Derde MP. Captopril treatment of chronic heart failure in the very old. J Gerontol 1994;49:M148–M152.[Medline]
20.O'Keeffe ST, Lye M, Donnnellan C, Carmichael DN. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart 1998;80:377–382.[Abstract/Free Full Text]
21.Bernstein ML, Despars JA, Singh NP, Avalos K, Stansbury DW, Light RW. Re-analysis of the 12 minute walk in patients with COPD. Chest 1994;105:163–167.[Abstract/Free Full Text]
22.Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with COPD. Am J Respir Crit Care Med
1998;158:1185–1189.[Abstract/Free Full Text]